12TH SEMI-ANNUAL LIFE SCIENCE CFO STRATEGIC GOVERNANCE FORUM

JUNE 14-15, 2018 | BOSTON, MA

HILTON BACK BAY

DOWNLOAD AGENDAREGISTER NOW

SCHEDULE-AT-A-GLANCE

DAY ONE AGENDA – THURSDAY, JUNE 14
LOCATION: ADAMS

7:45 REGISTRATION & WELCOME COFFEE

8:30 OPENING REMARKS & PROGRAM WELCOME

LOCATION: WASHINGTON

8:45 KEYNOTE PANEL DISCUSSION: CURRENT & FUTURE CHALLENGES & OPPORTUNITIES IN LIFE SCIENCES
The Life Sciences industry is one of progress and opportunity, yet constant change and uncertainty. Heading into the second half of 2018 and beyond, pharmaceutical, biotechnology, medical device and diagnostic companies are having to effectively manage a variety of key areas, including regulatory, legislative and technological changes and enhancements, where there are currently unknowns. As policy and other important decisions are being made, Life Sciences financial executives will have to be prepared for the outcomes. Panelists will discuss the challenges and opportunities organizations are facing and how to prepare for a variety of possible scenarios while effectively managing risk.

PANELISTS:
Julie Hakim, Vice President, Finance & Administration, LUNDBECK LLC

Nick Cala, Vice President of Industry Relations, CARDINAL HEALTH

Steven Lesiak, Vice President, Finance & Operations, ILSE, PROKARYOTICS, INC.

 

9:15 HOW EINSTEIN’S DEFINITION OF INSANITY COULD WREAK HAVOC IN YOUR LIFE SCIENCE BUSINESS
Property and casualty insurance for the average corporation in the Life Science industry is extremely complex and far outside the scope of the average local insurance broker that insures restaurants, contractors and general businesses. To say “the devil is in the detail” would be quite an understatement. During this presentation you will learn through various client case studies the systematic steps and decision logic needed to avoid the “havoc” and most optimally protect shareholder value.

Matthew L. Cohn, Senior Vice President, ALLIANT LIFE SCIENCES

10:00 PRE-SCHEDULED NETWORKING MEETINGS & COFFEE BREAK
LOCATION: ADAMS

PLEASE SELECT FROM THE FOLLOWING BREAKOUT SESSIONS:

LOCATION: LINCOLN

LOCATION: JEFFERSON

11:30 NEW METHODS FOR REVENUE RECOGNITION UNDER ASC 606

Igor Gitelman, Chief Accounting Officer, CANCER GENETICS, INC.

11:30 LONG-TERM STRATEGY FOR MANUFACTURERS: OUTSOURCING OR INSOURCING TO AUTOMATE CONTRACTING & GROSS-TO-NET FUNCTIONS

Krishnan Padmanabhan, Co-founder, President & Chief Operating Officer, DAVIZTA, INC.

12:15 LUNCHEON FOR ALL PARTICIPANTS & GUESTS
LOCATION: ADAMS

1:15 BALANCING GROWTH TO DRIVE INNOVATION & BUSINESS

Nick Calla, Vice President of Industry Relations, CARDINAL HEALTH

 

2:00 OPTIMIZATION OF GROSS-TO-NET PROCESSES & CONTROLS

Frank Panaro, Director, Financial Gross-to-NetPURDUE PHARMA L.P.

1:15  PRIORITIZATION OF SPENDING & FINANCIAL ACCOUNTABILITY

Tomás Morales-Navarro, CMA, Finance Controller, Janssen Research & DevelopmentJOHNSON & JOHNSON

 

2:00 AREAS OF NEW GUIDANCE FROM FASB & PCAOB, INCLUDING ASC 842

Rob Auslander, Vice President, Technical Accounting & Policies, VALEANT PHARMACEUTICALS

2:45 PRE-SCHEDULED NETWORKING MEETINGS & COFFEE BREAK
LOCATION: ADAMS

3:45 POSITIONING OF FINANCE AS A VALUE-ADD BUSINESS PARTNER

Steven Lesiak, Vice President, Finance & Operations, ILSE, PROKARYOTICS, INC.

 

4:30 LONG-TERM STRATEGIC PLANNING ALIGNED WITH CORPORATE VISION

Michelle Delaney, Executive Director, FP&A, SUNOVIAN PHARMACEUTICALS

3:45 UTILIZATION OF ROLLING FORECASTS TO INCREASE FINANCIAL AGILITY

Akin Ayemobola, Director, FP&A, IT Finance, CARDINAL HEALTH

 

4:30 IMPACT OF M&A ACTIVITY ON FINANCIAL OPERATIONS

Igor Gitelman, Chief Accounting Officer, CANCER GENETICS, INC.

LOCATION: ADAMS
5:15 PRE-SCHEDULED NETWORKING MEETINGS & COCKTAIL HOUR

 

6:15 DAY 1 PROGRAM CONCLUSION

 

7:00 FACILITATED GROUP NETWORKING DINNER
Q1 Productions has made a dinner reservation at Stephanie’s, a nearby restaurant, on Thursday, June 14, for a group of 10-15 participants. For those who are interested, this is a great opportunity to join fellow forum participants for further networking, idea sharing and good conversation.

DAY TWO AGENDA – FRIDAY, JUNE 15
LOCATION: ADAMS

7:45 REGISTRATION & WELCOME COFFEE 

PLEASE SELECT FROM THE FOLLOWING BREAKOUT SESSIONS:

LOCATION: LINCOLN

LOCATION: JEFFERSON

8:30 MODELING & ACCOUNTING FOR LICENSING FEES

Suchitra Batra, Associate Director, BD & Alliance Management, SANDOZ

Ayushman Hazarika, Associate Director, Financial Reporting & Accounting, NOVARTIS

 

9:15 ALIGNMENT OF FINANCIAL GOALS FOR COMMERCIAL WITH R&D

Dave Lehman, Senior Director, Finance, PFIZER

8:30 ACCOUNTING FOR DISCOUNTS, REBATES & COMMERCIAL INCENTIVES

Rob Auslander, Vice President, Technical Accounting & PoliciesVALEANT PHARMACEUTICALS

 

9:15 OPTIMIZATION OF GROSS-TO-NET PROCESSES & CONTROLS

Peter Licata, Chief Financial Officer, EDENBRIDGE PHARMACEUTICALS

10:00 PRE-SCHEDULED NETWORKING MEETINGS & COFFEE BREAK
LOCATION: ADAMS

11:30 POSITIONING OF FINANCE AS A VALUE-ADD BUSINESS PARTNER

Matthew Lesniewski, Director, Finance Business Partner, PAREXEL INTERNATIONAL

11:30 IMPACT OF M&A ACTIVITY ON FINANCIAL OPERATIONS

Peter Licata, Chief Financial OfficerEDENBRIDGE PHARMACEUTICALS

12:15 LUNCHEON FOR ALL PARTICIPANTS & GUESTS
LOCATION: ADAMS

1:15 BUILDING & MAINTAINING A HIGH PERFORMING FINANCE TEAM

Mila Tartakovsky, Executive Director, Business Decision SupportDAIICHI SANKYO

 

2:00 PLANNING, ACCOUNTING & CONTROLS RELATED TO R&D UPFRONT AND MILESTONE PAYMENTS

Anju Nagpal, Senior Director, Functional Finance & Control, BIOGEN

1:15 ALIGNING TEAM CULTURE WITH FINANCIAL STRATEGY & GOVERNANCE

Steven Lesiak, Vice President, Finance & Operations, ILSE, PROKARYOTICS, INC.

 

2:00 PREDICTIVE ANALYTICS TO DRIVE OPERATIONAL VALUE

Dave Lehman, Senior Director, FinancePFIZER

2:45 CLOSING REMARKS & FORUM CONCLUSION

Share This